{{Rsnum
|rsid=17374749
|Chromosome=3
|position=137049168
|Orientation=plus
|GMAF=0.2433
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 41.6 | 51.3
| HCB | 0.0 | 15.3 | 84.7
| JPT | 0.0 | 8.0 | 92.0
| YRI | 22.4 | 44.9 | 32.7
| ASW | 19.3 | 49.1 | 31.6
| CHB | 0.0 | 15.3 | 84.7
| CHD | 0.0 | 22.0 | 78.0
| GIH | 2.0 | 26.7 | 71.3
| LWK | 25.7 | 44.0 | 30.3
| MEX | 3.4 | 19.0 | 77.6
| MKK | 12.8 | 43.6 | 43.6
| TSI | 9.8 | 34.3 | 55.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs17374749
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084216
|Annotation=In a multi-stage case-control study of Type I Diabetes Mellitus patients from Finland, Iceland and the British Isles, this SNP(rs17374749 G allele) was part of a haplotype associated with risk of Diabetic Nephropathy . The other tag SNPs for the haplotype are rs6766709 (T),rs1866813(C) and rs16844489(T).
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus, Type 1; Diabetic Nephropathies
|Curation Level=Curated
|PharmGKB Accession ID=PA164857073
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs17374749
|overall_frequency_n=40
|overall_frequency_d=128
|overall_frequency=0.3125
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=32
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}